Skip to content


Hivid, Dacogen (tezacitabine) is a small molecule pharmaceutical. Tezacitabine was first approved as Hivid on 1992-06-19. It has been approved in Europe to treat myeloid leukemia.
Trade Name Dacogen
Common Name Tezacitabine
Indication myeloid leukemia
Drug Class Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives
Get full access now